The Use of Drugs for Cardioversion of Recent Onset Atrial Fibrillation and FlutterFocus on Ibutilide

被引:0
|
作者
Owen A. Obel
A. John Camm
机构
[1] St George’s Hospital Medical School,Department of Cardiological Sciences
来源
Drugs & Aging | 1998年 / 12卷
关键词
Atrial Fibrillation; Adis International Limited; Amiodarone; Sinus Rhythm; Flecainide;
D O I
暂无
中图分类号
学科分类号
摘要
Atrial fibrillation (AF) is the most common sustained arrhythmia, particularly in the elderly population. It is well recognised that AF is a major cause of stroke, even in the absence of underlying heart disease. Although AF and atrial flutter share many causes and may be seen in the same patient, there are differences between these arrhythmias: atrial flutter is less common, and the risk of stroke associated with it is less than that with AF. In addition to stroke, both AF and atrial flutter may cause cardiomyopathy, which may be fully reversible with effective treatment of the arrhythmia. Both AF and atrial flutter can result in severe symptoms and may precipitate heart failure, ischaemia and syncope. Recent research indicates that AF is a self-perpetuating arrhythmia, and that the longer it is left untreated the less likely it is that effective cardioversion will be possible.
引用
收藏
页码:461 / 476
页数:15
相关论文
共 50 条
  • [41] Electrical cardioversion for atrial fibrillation
    Laszlo, R.
    Laszlo, S.
    Graze, H.
    Schreieck, J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 (15) : 750 - 754
  • [42] Clinical Efficacy and Safety of Ibutilide in Cardioversion of Atrial Fibrillation or Flutter in Indian Patients: A Multicenter Study
    Dewan, Bhupesh
    Navale, Sanjaykumar
    Shinde, Siddheshwar
    Chaudhary, Janaki
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2025, 29 (01) : 45 - 51
  • [43] Remodeling by atrial fibrillation: clinical implications for cardioversion
    Ehrlich, J. R.
    Goette, A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (43) : 2212 - 2216
  • [44] Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation
    Zhang, N
    Guo, JH
    Zhang, HC
    Li, XB
    Zhang, P
    Xn, Y
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (12) : 1395 - 1400
  • [45] Is pretreatment with ibutilide useful for atrial fibrillation cardioversion when combined with biphasic shock?
    Mazzocca, Gianfranco
    Corbucci, Giorgio
    Venturini, Elio
    Becuzzi, Lucia
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2006, 7 (02) : 124 - 128
  • [46] Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy
    Glatter, K
    Yang, YF
    Chatterjee, K
    Modin, G
    Cheng, J
    Kayser, S
    Scheinman, MM
    CIRCULATION, 2001, 103 (02) : 253 - 257
  • [47] Ibutilide for pharmacological cardioversion of atrial flutter
    K Magnusson
    T Othman
    NA Cicco
    EG Vester
    Critical Care, 6 (Suppl 1):
  • [48] "Pill in the Pocket" Antiarrhythmic Drugs for Orally Administered Pharmacologic Cardioversion of Atrial Fibrillation
    Reiffel, James A.
    Capucci, Alessandro
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 140 : 55 - 61
  • [49] Intravenous VernakalantA Review of its Use in the Management of Recent-Onset Atrial Fibrillation
    Sean T. Duggan
    Lesley J. Scott
    Drugs, 2011, 71 : 237 - 252
  • [50] Safety of emergency-department electric cardioversion for recent-onset atrial fibrillation
    Carbajosa-Dalmau, Jose
    Martin, Alfonso
    Paredes-Arquiola, Laura
    Jacob, Javier
    Coll-Vinent, Blanca
    Llorens, Pere
    EMERGENCIAS, 2019, 31 (05): : 335 - 340